Long Versus Short Axis Approach for Ultrasound Guided Peripheral

Clinical Trial Description

Patients needing an USGPIV will be randomized into long or short axis orientation. Emergency Medicine residents will place the IV using an ultrasound. ;

Study Design

Related Conditions & MeSH terms

Venous Access

See also
Status	Clinical Trial	Phase
Completed	`NCT04382430` - Ultrasound Axillary Vein Access: Evaluation of Learning Curve for an Alternative Approach to Cardiac Device Implantation	N/A
Completed	`NCT04036734` - Longitudinal or Transverse Orientation of Ultrasound Probe in Minimally Invasive Venous Surgery.	N/A
Completed	`NCT05519787` - A Retrospective, Observational, Monocenter, Study to Describe the Utilization and Overall Safety and Performance of POLYSITE®/SEESITE® Implantable Ports

See also

Status

Clinical Trial

Phase

Completed

NCT04382430 - Ultrasound Axillary Vein Access: Evaluation of Learning Curve for an Alternative Approach to Cardiac Device Implantation

N/A

Completed

NCT04036734 - Longitudinal or Transverse Orientation of Ultrasound Probe in Minimally Invasive Venous Surgery.

N/A

Completed

NCT05519787 - A Retrospective, Observational, Monocenter, Study to Describe the Utilization and Overall Safety and Performance of POLYSITE®/SEESITE® Implantable Ports

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04234347
Study type	Interventional
Source	Temple University
Contact	Ryan C Gibbons, MD
Phone	6106137408
Email	ryan.gibbons@tuhs.temple.edu
Status	Not yet recruiting
Phase	N/A
Start date	May 1, 2024
Completion date	December 1, 2025

Long Versus Short Axis Approach for Ultrasound Guided Peripheral Intravenous Access

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms